TABLE 1.
Binding affinity constants for the α2A-, α2B-, and α2A-adrenoceptors of clonidine and the antagonists used in the present study. The nanomoles (and their equivalents in μg) spinally administered in the current experiments are also shown.
| Affinity values (pK i or pK D) for α2-adrenoceptor subtypes | Nanomoles (nmol) and their equivalents in μg used in the present study | |||
|---|---|---|---|---|
| α2A | α2B | α2C | ||
| Clonidine a | 7.2 | 7.2 | 6.9 | 0.1 nmol (0.02 μg) |
| 1.0 nmol (0.2 μg) | ||||
| 10.0 nmol (2.0 μg) | ||||
| BRL 44408 b | 7.2 | 5.4 | 6.2 | 0.1 nmol (0.22 μg) |
| 1.0 nmol (2.2 μg) | ||||
| Imiloxan b | 5.9 | 6.5 | 6.3 | 10 nmol (2.44 μg) |
| JP-1302 b | 5.3 | 5.1 | 6.9 | 1 nmol (0.37 μg) |
| 10 nmol (3.7 μg) | ||||
All data are given as pK i.
(Jasper et al., 1998) or pK D.
(Proudman et al., 2022) values at human receptors.